Dengue Surveillance in Guadeloupe and the Northern Islands. Update as of March 26, 2021

Key points

Guadeloupe, Saint Martin, and Saint Barthélemy

All dengue surveillance indicators are at low levels for the three territories, both in primary care and in hospitals.

In Guadeloupe, the number of weekly reported medical consultations for suspected dengue has been below the seasonal threshold for the past four weeks, and the predominant circulating serotype is DENV-2, with DENV-1 and DENV-3 circulating concurrently.

In Saint Martin and Saint Barthélemy, the predominant circulating serotype is DENV-1.

In February and March 2021, the technical committees monitoring dengue, consulted in each of the three territories, proposed the end of the epidemic and a return to normal, in accordance with the respective PSAGE* guidelines. This proposed phase change will be submitted for validation to the management unit, which is expected to meet shortly.

Nevertheless, preventive measures should continue to be implemented (destruction of larval breeding sites, personal protection with repellents, use of mosquito nets and electric fly swatters) to reinforce this imminent transition out of the epidemic phase.

In relation to

Our latest news

news

Etienne Pot Appointed Interim Director General of Santé publique France

news

Arboviral Diseases in 2026: Mosquito-Borne Diseases Continue to Spread This...

news

Andes Hantavirus: Implementation of epidemiological investigations and...